SET Announcements

Change of director/Executive Agenda 7. To consider the relieve of a director before terms expires, Facts and reasons: According to Section 76 of the Articles of Association of the Public Limited Company Act that the shareholders probably vote to relieve any the director before terms expires Board's opinions: The Board feels appropriate to ask shareholders in the meeting to relieve Miss. Ratana Chantrawongsakorn, Director before terms expires as cause unavailable on Board's meeting. Agenda 8. To consider the vacancy director position Facts and reasons: According to Section 76 of the Articles of Association of the Public Limited Company Act that the director who is appointed will be in the remaining term of the former position. Board's opinions: The Board agrees with the Recruitment Committee's opinions appoint Mr. Kasidit Ajanant to be a director and Independent director as replace. Agenda 9. To elect Directors to replace Directors whose terms expires, Facts and reasons: Section 9 of the Articles of Association and Section 71 of the Public Limited Company Act require one third of the number of Directors to leave the office but the outgoing Directors may be reinstated. Out of the 15-director Board, the following 5 Directors have to leave the office are as follows: (1) Mr. Banthun Junhasavasdikul, Director and Chairman of the Recruitment Committee, (2) Mr. Jarun Wiwatjesadawut, Director and Member of the Recruitment Committee, (3) Mr. Sanya Sarayudh, Vice Chairman and Executive Director, (4) Mr. Somphol Wongaurai, Executive Director, (5) Dr. Atirat Charoonsri, Managing Director. Board's opinions: The Board agrees with the Recruitment Committee's opinions and advice to propose to shareholders in the general meeting to reinstate the 4 outgoing Directors as follows: (1) Mr. Banthun Junhasavasdikul, Director and Chairman of the Recruitment Committee, (2) Mr. Jarun Wiwatjesadawut, Director and Member of the Recruitment Committee, (3) Mr. Sanya Sarayudh, Vice Chairman and Executive Director, (4) Dr. Atirat Charoonsri, Managing Director and appoint Mr. Sucheep Boonveera to be a director and Independent director. ______________________________________________________________________ Dividend consideration Subject : Cash dividend payment Date of Board resolution : 13-Mar-2012 Type of dividend payment : Cash dividend payment Record date for the right to receive : 28-Mar-2012 dividends Book closing date for collecting : 29-Mar-2012 shareholders names under Section 225 of the Securities and Exchange Act Ex-dividend date : 26-Mar-2012 Payment for : Common shareholders Cash dividend payment (baht per share) : 0.60 Par value (baht) : 6.50 Payment date : 24-May-2012 Paid from : Operating period from 01-Jan-2011 to 31-Dec-2011 ______________________________________________________________________ Meeting schedule of securities holders Subject : Schedule of Annual General Meeting of Shareholders Date of Board resolution : 13-Mar-2012 Meeting date (Update) : 25-Apr-2012 Beginning time of meeting (h:mm) : 09 : 00 (Update) Record date for the right to attend the : 28-Mar-2012 meeting Book closing date for collecting holders : 29-Mar-2012 names under Section 225 of the Securities and Exchange Act Ex-meeting date : 26-Mar-2012 Significant agenda item (Update) : - Dividend payment - Changing the director(s) Venue of the meeting : Meeting Room 2 Floor, Building 1, Sikarin Hospital, No 4/29 Moo 10 Srinakarin Road, Bang Na Sub-dustrict, Bang Na District, Bangkok ______________________________________________________________________ This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.